Pharma Journalist -

X-Chem, Inc. announced the appointment of Christelle Huguet, Ph.D. as Chief Scientific Officer, along with an executive leadership appointment for Matthew Clark, Ph.D. as Senior Vice…
Read More...

Dr. Reddy’s Laboratories Ltd announced that it has launched Levocetirizine Dihydrochloride Tablets USP, 5 mg, an over-the-counter therapeutic equivalent generic version of Xyzal Allergy…
Read More...

Dalton Pharma Services has declared the signing of a drug development and manufacturing services agreement with Oryn Therapeutics, an American biotechnology firm committed to the…
Read More...

Certara announced the launch of its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium. QSP combines computational modeling and experimental methods to…
Read More...

Proteostasis Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for PTI-428, the Company’s cystic fibrosis transmembrane…
Read More...

MEDISCA announced that an out-licensing agreement has been signed with California-based Torrey Hills Technologies Inc., for its innovative ointment mill cleaning tool for ProMill™. The…
Read More...

One in 10 people in America is fighting a rare disease, or a disorder that affects fewer than 200,000 Americans. Although there are more than 7,000 rare diseases that collectively…
Read More...

Bio-Techne has released MimEX™ GI, a new product line for generating 3-dimensional (3-D) gastrointestinal tissue on a 2-D surface. 3-D cell culture and organoid models of the…
Read More...

Ionis Pharmaceuticals and Akcea Therapeutics announced an exclusive, worldwide license by Ionis to Akcea for inotersen and AKCEA-TTR-LRx, formerly IONIS-TTR-LRx, in a transaction…
Read More...

Recipharm, the contract development and manufacturing organisation (CDMO), announces its new Blow-fill-seal machinery is now operational following a substantial investment last year at…
Read More...